SPTX logo

Seaport Therapeutics, Inc. Common Stock

SPTX
Healthcare|Biotechnology|US
$21.50
+1.11 (+5.44%)
DCF Value
$1.08
Tangible Book / Share
$7.42
Cash / Share
$5.43
Next Earnings Report
Feb 1, 2027
EPS est. -$0.59
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest May 1, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Seaport Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Nov 2, 2026 · Business Wire
PureTech Founded Entity Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress
Oct 9, 2026 · Business Wire
Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress
Oct 9, 2026 · Business Wire
PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgo™ in Patients with Generalized Anxiety Disorder and Sleep Disturbance
Oct 7, 2026 · Business Wire
Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgoTM in Patients with Generalized Anxiety Disorder and Sleep Disturbance
Oct 7, 2026 · Business Wire
Seaport Therapeutics to Participate in September Investor Conferences
Sep 14, 2026 · Business Wire
PureTech Founded Entity Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
Sep 9, 2026 · Business Wire
Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
Sep 9, 2026 · Business Wire

SEC Filings (24)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 2, 202610-QQuarterly reportDocumentIndex
Nov 2, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 5, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 5, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 3, 202610-QQuarterly reportDocumentIndex
Aug 3, 20268-KMaterial eventDocumentIndex
Jun 8, 202610-QQuarterly reportDocumentIndex
Jun 8, 20268-KMaterial eventDocumentIndex
May 11, 2026SC 13DActivist / 5%+ stakeDocumentIndex
May 11, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 6, 2026SC 13DActivist / 5%+ stakeDocumentIndex
May 4, 20268-KMaterial eventDocumentIndex
May 4, 2026S-8Employee stock planDocumentIndex
May 1, 2026424B4Offering prospectusDocumentIndex
Apr 30, 2026EFFECTDocumentIndex
Apr 30, 2026S-1MEFIPO / offering registrationDocumentIndex
Apr 30, 2026CERTDocumentIndex
Apr 28, 20268-A12BDocumentIndex
Apr 27, 2026S-1/AIPO / offering registrationDocumentIndex
Apr 10, 2026S-1IPO / offering registrationDocumentIndex
Feb 27, 2026DRS/ADocumentIndex
Jan 29, 2026DRS/ADocumentIndex
Nov 21, 2025DRSDocumentIndex